Heidi Glosli

6PUBLICATIONS
57CO-AUTHORS
Infant and child healthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 14, 2026
Plain Language Summary on Safety and Efficacy of Damoctocog Alfa Pegol in Previously Treated Children Aged 7 to < 12 Years With Severe Haemophilia A in the Phase 3, Open Label Alfa-PROTECT Main Study.

Margareth C Ozelo, Matteo Luciani, Heidi Glosli

|Jan 05, 2026
Safety and Efficacy of Damoctocog Alfa Pegol in Previously Treated Children Aged 7 to < 12 Years With Severe Haemophilia A in the Phase 3, Open Label Alfa-PROTECT Main Study.

Margareth C Ozelo, Matteo Luciani, Heidi Glosli

|Apr 28, 2025
Immune Tolerance Induction With a Recombinant Factor VIII Fc in Haemophilia A: Data From a Chart Review Study.

Robert Klamroth, Mahasen Al Saleh, Heidi Glosli

|Mar 07, 2025
Maintenance Chemotherapy in Patients With High-Risk Rhabdomyosarcoma: Long-Term Survival Analysis of the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 Trial.

Gianni Bisogno, Julia Chisholm, Raquel Hladun

|Sep 08, 2023
Quantitative diffusion-weighted MRI response assessment in rhabdomyosarcoma: an international retrospective study on behalf of the European paediatric Soft tissue sarcoma Study Group Imaging Committee.

Roelof van Ewijk, Cyrano Chatziantoniou, Madeleine Adams

|Feb 27, 2023
Nonmetastatic Rhabdomyosarcoma in Children and Adolescents: Overall Results of the European Pediatric Soft Tissue Sarcoma Study Group RMS2005 Study.

Gianni Bisogno, Veronique Minard-Colin, Ilaria Zanetti

Pageof 1

Frequent Collaborators

3 joint publications

Gianni Bisogno

3 joint publications

Veronique Minard-Colin

3 joint publications

Andrea Ferrari

3 joint publications

Henry Mandeville